Tysabri every eight weeks may cut PML risk
Tysabri every eight weeks may cut PML risk
Preliminary findings from an ongoing study of multiple sclerosis patients suggest the dosing interval for Tysabri can be as much as doubled from the label-recommended standard without sacrificing efficacy, and with potentially less risk of progressive multifocal leukoencephalopathy (PML) -- even among patients with more than average PML risk, researchers claim... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2173 Views
-
Last post by NHE
-
- 6 Replies
- 4692 Views
-
Last post by ElliotB
-
- 0 Replies
- 1276 Views
-
Last post by NHE
-
- 0 Replies
- 3242 Views
-
Last post by NHE
-
- 0 Replies
- 1557 Views
-
Last post by NHE
-
- 1 Replies
- 964 Views
-
Last post by NHE
-
- 1 Replies
- 1420 Views
-
Last post by NHE
-
- 11 Replies
- 3211 Views
-
Last post by NHE
-
- 0 Replies
- 3033 Views
-
Last post by NHE